IMA Clinical Research Monroe - Armand

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Type 2 diabetes3 trials
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Heart failure1 trial
• Peripheral artery disease1 trial
• Stroke1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Completed1 trial

Lead sponsor

• Eli Lilly and Company3 trials
• Regeneron Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

  NCT07232719· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

  NCT06260722· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

  NCT06299098· Phase 2· Regeneron Pharmaceuticals· Source